Records containing: Pulmonary Arterial Hypertension

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-06-04
  An Open Label Pilot Study Evaluating Preliminary Safety and Performance of the GeNO Nitrosyl Delivery System
• CLINICAL_TRIALS study record update · 2013-05-17
  COMPASS 3: An Open-label, Multi-Center Study Employing a Targeted 6-Minute Walk Test (6-MWT) Distance Threshold Approach to Guide Bosentan-Based Therapy and to Assess the Utility of Magnetic Resonance Imaging (MRI) on Cardiac Remodeling
• CLINICAL_TRIALS study record update · 2013-04-12
  Inhaled Iloprost for Sarcoidosis Associated Pulmonary Hypertension
• CLINICAL_TRIALS study record update · 2013-04-12
  Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
• CLINICAL_TRIALS study record update · 2013-03-07
  A Multicenter, Randomized, Parallel Placebo-Controlled Study of the Safety and Efficacy of Subcutaneous Remodulin® Therapy After Transition From Flolan® in Patients With Pulmonary Arterial Hypertension
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2013-02-25
  Pulmonary Artery Remodelling With Bosentan
• CLINICAL_TRIALS study record update · 2013-02-20
  An Open Label, Multi-center Study Evaluating the Safety of Long-term Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
• CLINICAL_TRIALS study record update · 2013-02-15
  A Phase IIIb, Multicenter, Open-label Study of Patients With Pulmonary Arterial Hypertension Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When Converting From Power Disc-6 (PD-6) to Power Disc-15 (PD-15) With the I-neb® AAD®
• CLINICAL_TRIALS study record update · 2013-01-15
  A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)
• CLINICAL_TRIALS study record update · 2012-11-09
  A Phase 1, Placebo Controlled, Blinded, Multiple Dose Escalation Study of AIR001 (Sodium Nitrite Inhalation Solution) in Healthy Subjects, an Assessment of the Tolerability in Combination With Oral Sildenafil, and an Open-Label Study of Multiple Dose AIR001 in Patients With Pulmonary Arterial Hypertension
• CLINICAL_TRIALS study record update · 2012-11-05
  Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
• CLINICAL_TRIALS study record update · 2012-10-31
  Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
• CLINICAL_TRIALS study record update · 2012-10-29
  A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
• CLINICAL_TRIALS study record update · 2012-10-26
  A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension
• CLINICAL_TRIALS study record update · 2012-10-04
  Reproducibility and Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
• CLINICAL_TRIALS study record update · 2012-08-23
  A Phase IV, Open-label, Randomized, Multicenter Study of the Safety, Tolerability,and Pharmacokinetics of ACT- 385781A Compared to Flolan® in Injectable Prostanoid Treatment-naïve Patients With Pulmonary Arterial Hypertension (PAH)
• CLINICAL_TRIALS study record update · 2012-08-23
  An Open-label Extension of Study AC-066A401 Investigating the Safety and Tolerability of ACT-385781A Compared to Flolan® in Injectable Prostanoid Treatment-naïve Patients With Pulmonary Arterial Hypertension (PAH)
• CLINICAL_TRIALS study record update · 2012-08-06
  ClinicalTrials.gov study NCT01352026
• CLINICAL_TRIALS study record update · 2012-07-30
  An Open-label, Multicenter Study of Ambrisentan and a Phosphodiesterase Type-5 Inhibitor Combination Therapy in Subjects With Pulmonary Arterial Hypertension Who Have Demonstrated a Sub-Optimal Response to a Phosphodiesterase Type-5 Inhibitor
• CLINICAL_TRIALS study record update · 2012-07-25
  ClinicalTrials.gov study NCT01649739
• CLINICAL_TRIALS study record update · 2012-06-25
  A Two-stage Prospective Observational Cohort Study in Scleroderma Patients to Evaluate Screening Tests and the Incidence of Pulmonary Arterial Hypertension and Pulmonary Hypertension
• CLINICAL_TRIALS study record update · 2012-06-08
  NON-INTERVENTIONAL (NI) DRUG STUDY PROTOCOL: THREE-COUNTRY PILOT STUDY FOR RETROSPECTIVE CHART REVIEW OF EFFECTIVENESS OF THELIN® (SITAXSENTAN) IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
• CLINICAL_TRIALS study record update · 2012-05-17
  An Evaluation of the Pharmacokinetics and Safety of a Single Dose of UT-15C SR (Treprostinil Diethanolamine) in Subjects With Renal Impairment.
• CLINICAL_TRIALS study record update · 2012-05-14
  A Multinational, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
• CLINICAL_TRIALS study record update · 2012-04-24
  A Long-Term, Open-Label Study To Evaluate The Safety Of Sitaxsentan Sodium Treatment In Patients With Pulmonary Arterial Hypertension